Muscle Strength Training for Older Adults With Type II Diabetes

Effects of Muscle Strength Training on Glycemic Control, Muscle Mass, Muscle Strength and Functional Capacity in Older Adults With Type II Diabetes: A Randomised Controlled Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03280758

Enrollment

Registered

2017-09-12

Start date

2017-10-01

Completion date

2019-08-30

Last updated

2017-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Keywords

Resistance training, Diabetes Mellitus, blood-glucose control, Muscle, Function

Brief summary

This randomised controlled trial aims to investigate a resistance training program for improving glycemic control, muscle mass, strength and functional performance in older patients with Type II Diabetes (T2 DM). 60 subjects will be randomly allocated to either a muscle strengthening group or a no exercise control group. Muscle strengthening group will receive resistance training 3 times per week (1 hour/session). The control group will not receive any training but can continue usual medical care and daily activities. Primary outcomes: glycemic control and lipid profile Secondary outcomes: muscle mass and strength, and functional capacity Data will be collected at baseline (pre-test) and after a 4-month intervention (post-test).

Detailed description

This study aims to investigate a resistance training program for improving glycemic control, muscle mass, strength and functional performance in older patients with Type II Diabetes (T2 DM). This is a single-blinded, randomized controlled trial. 60 subjects will be randomly allocated to either a muscle strengthening group or a no exercise control group. Information on demographic characteristics, body composition, muscle strength, functional capacity and glycemic control will be collected at baseline (pre-test) and after a 4-month intervention (post-test). Muscle strengthening group will receive resistance training 3 times per week (1 hour/session). The control group will not receive any training but can continue usual medical care and daily activities.

Interventions

BEHAVIORALMuscle Strengthening exercises

Participants will be required to participate in resistance training 3 hours per week.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Masking description

The outcome assessor will not know the intervention of each subjects

Eligibility

Sex/Gender

ALL

Age

60 Years to 75 Years

Healthy volunteers

Inclusion criteria

* T2 DM * 60-75 years old * ability to perform exercise

Exclusion criteria

* Advanced hypertension (≥ 160/100 mm Hg) * severe obesity (BMI ≥ 48kg/m2) * insulin pump user * coronary heart disease history * chronic obstructive pulmonary disease * advanced neuropathy * learning or mental disorder, or * any other diseases that prevent subjects from exercising safely. * Those who participate in regular resistance or aerobic exercises will also be excluded.

Design outcomes

Primary

Measure	Time frame	Description
Fasting glucose level	4 months	—
Lipid profiles	4 months	HDL, LDL, Trig

Secondary

Measure	Time frame	Description
Muscle strength	4 months	Whole body
Muscle mass	4 months	Whole body
Functional performance	4 months	Walking ability

Contacts

Primary ContactSiu Ming Fong, PhD

smfong@hku.hk28315260

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026